This article was originally published by Christopher M. Holman* in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Despite the important role of intellectual property rights in…
The p…
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Read Post »
This paper was originally published by Maya Tannoury and Zouhair Attieh in Current Therapeutic Research under a creative commons license. Abstract Emerging markets represent an exceptional opportunity for the pharmaceutical…
The post The Influence of …
The Influence of Emerging Markets on the Pharmaceutical Industry Read Post »
When drugs are taken off the market because of concerns about their safety, it makes headlines. To access DrugPatentWatch’s list of discontinued drugs try a free trial or contact us…
The post Reviving a Discontinued Drug appeared first on DrugPatentWat…
Here’s a copy of the recent talk on Finding and Evaluating Branded and Generic Market Entry Opportunities. It’s based on the book Make Better Decisions, which distills insights gained from…
The post Finding and Evaluating Branded and Generic Market Ent…
Finding and Evaluating Branded and Generic Market Entry Opportunities Read Post »
You would be surprised to find out just how many questions are answered by the analysis of the relationship that emerges between generic competition and drug prices. For manufacturers and…
The post Drug Prices and Generic Competition appeared first on…
Valuing pharma companies isn’t the same as valuing non-pharma companies, for several reasons. Traditional business considerations are compounded by patent law and FDA approval processes when evaluating the investment potential of…
The post Valuation of…
Valuation of Pharma Companies: 5 Key Considerations Read Post »
Amid public outcry over rising costs of brand-name drugs, the prices of generic medicines have been falling, raising fears about the sustainability and profitability of major generics companies. But some…
The post Opportunities for Generic Drug Develop…
This paper was originally published by Melek Simsek, Berrie Meijer, Adriaan A.van Bodegraven, Nanne K.H. de Boer, and Chris J.J. Mulder in Drug Discovery Today Volume 23, Issue 1, January…
The post Finding hidden treasures in old drugs: the challenges …
When referring to “big data” in the context of the drug industry, one should essentially think of a collection of datasets with the help of which companies are able to…
The post How Big Data Is Remodelling The Drug Industry appeared first on DrugPatent…
This paper was originally published by Ingrid Freije, Stéphane Lamouche, and Mario Tanguay in Therapeutic Innovation & Regulatory Science under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/…